| 1 |
35229019 | Lack of association between bridging integrator 1 (BIN1) rs744373 polymorphism and tau-PET load in cognitively intact older adults. | 2022 |
1 |
| 2 |
33122395 | In vivo PET imaging of neuroinflammation in familial frontotemporal dementia. | 2021 Mar |
1 |
| 3 |
33460010 | Radioactive synthesis of tau PET imaging agent 18F-AV-1451 and its role in monitoring the progression of Alzheimer's disease and supporting differential diagnosis. | 2021 Feb |
1 |
| 4 |
33594726 | Significant effects of cholinesterase inhibitors on tau pathology in the Alzheimer's disease continuum: An in vivo positron emission tomography study. | 2021 Aug |
1 |
| 5 |
33631469 | Imaging tau burden in dementia with Lewy bodies using [18F]-AV1451 positron emission tomography. | 2021 May |
1 |
| 6 |
30073880 | Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake. | 2019 Nov |
1 |
| 7 |
30468693 | MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy. | 2019 Jan |
1 |
| 8 |
30635491 | The influence of β-amyloid on [18F]AV-1451 in semantic variant of primary progressive aphasia. | 2019 Feb 12 |
1 |
| 9 |
28884232 | [18F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP. | 2018 Mar |
1 |
| 10 |
29278274 | The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases. | 2018 Feb |
2 |
| 11 |
29419480 | Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models. | 2018 Jun |
2 |
| 12 |
29605222 | Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease. | 2018 Aug |
2 |
| 13 |
29614676 | Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease. | 2018 |
1 |
| 14 |
27813160 | Subcortical 18 F-AV-1451 binding patterns in progressive supranuclear palsy. | 2017 Jan |
1 |
| 15 |
27863444 | AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies. | 2017 Jan |
2 |
| 16 |
27908967 | Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects. | 2017 Jul |
1 |
| 17 |
28256006 | In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography. | 2017 Jun |
1 |
| 18 |
28756238 | AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure. | 2017 Nov 1 |
1 |
| 19 |
29047416 | Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case. | 2017 Oct 19 |
1 |
| 20 |
26728162 | Human Radiation Dosimetry of [(18)F]AV-1451(T807) to Detect Tau Pathology. | 2016 Aug |
1 |
| 21 |
27296779 | An autoradiographic evaluation of AV-1451 Tau PET in dementia. | 2016 Jun 13 |
6 |
| 22 |
23411393 | [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. | 2013 Nov |
1 |